ES2443720T3 - Nuevos compuestos de unión al surco menor - Google Patents

Nuevos compuestos de unión al surco menor Download PDF

Info

Publication number
ES2443720T3
ES2443720T3 ES07823959.7T ES07823959T ES2443720T3 ES 2443720 T3 ES2443720 T3 ES 2443720T3 ES 07823959 T ES07823959 T ES 07823959T ES 2443720 T3 ES2443720 T3 ES 2443720T3
Authority
ES
Spain
Prior art keywords
methyl
amino
compound
carbonyl
pyrrol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07823959.7T
Other languages
English (en)
Spanish (es)
Inventor
Abedawn Khalaf
Colin Suckling
Roger Waigh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Strathclyde
Original Assignee
University of Strathclyde
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Strathclyde filed Critical University of Strathclyde
Application granted granted Critical
Publication of ES2443720T3 publication Critical patent/ES2443720T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES07823959.7T 2006-09-30 2007-09-28 Nuevos compuestos de unión al surco menor Active ES2443720T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0619325.4A GB0619325D0 (en) 2006-09-30 2006-09-30 New compounds
GB0619325 2006-09-30
PCT/GB2007/003698 WO2008038018A1 (en) 2006-09-30 2007-09-28 Novel minor groove binders

Publications (1)

Publication Number Publication Date
ES2443720T3 true ES2443720T3 (es) 2014-02-20

Family

ID=37434989

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07823959.7T Active ES2443720T3 (es) 2006-09-30 2007-09-28 Nuevos compuestos de unión al surco menor

Country Status (10)

Country Link
US (1) US8012967B2 (enExample)
EP (1) EP2066627B1 (enExample)
JP (1) JP5564257B2 (enExample)
CN (1) CN101589024B (enExample)
CA (1) CA2664847C (enExample)
DK (1) DK2066627T3 (enExample)
ES (1) ES2443720T3 (enExample)
GB (2) GB0619325D0 (enExample)
PL (1) PL2066627T3 (enExample)
WO (1) WO2008038018A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9072535B2 (en) 2011-05-27 2015-07-07 Ethicon Endo-Surgery, Inc. Surgical stapling instruments with rotatable staple deployment arrangements
WO2011150156A2 (en) * 2010-05-26 2011-12-01 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
CZ305332B6 (cs) * 2013-10-25 2015-08-05 Univerzita Karlova v Praze, Farmaceutická fakulta v Hradci Králové Použití derivátů pyrazinu a jejich isosterů jako sloučenin vážících se do malého žlábku DNA
CN105732583B (zh) * 2016-03-25 2018-05-04 苏州麦迪耐斯医药科技有限公司 一种治疗脑胶质母细胞瘤的靶向化合物
CN109715637B (zh) 2016-07-22 2022-04-05 百时美施贵宝公司 葡萄糖激酶激活剂及其使用方法
WO2018047148A1 (en) 2016-09-12 2018-03-15 Novartis Ag Compounds for the inhibition of mirna
JP7477858B2 (ja) * 2020-03-05 2024-05-02 国立大学法人電気通信大学 急性ｔリンパ芽球性白血病若しくはリンパ腫、又は急性骨髄性白血病治療用医薬組成物
GB202114032D0 (en) 2021-09-30 2021-11-17 Univ Strathclyde Antivirals
GB202206931D0 (en) 2022-05-12 2022-06-29 Univ Strathclyde Compounds
CN115109113B (zh) * 2022-05-31 2023-06-27 上海应用技术大学 一种胆固醇类衍生物有机凝胶因子及其制备方法和应用
CN116514698A (zh) * 2023-04-10 2023-08-01 佛山奕安赛医药科技有限公司 一种沃诺拉赞中间体的制备方法及其应用

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1886481A (en) * 1927-11-07 1932-11-08 Soc Of Chemical Ind Unilaterally acylated diamines and process of making same
DE2331444A1 (de) 1973-06-20 1975-01-23 Hoechst Ag Neue styryl-benzoxazole, verfahren zu deren herstellung und ihre verwendung als optische aufhellungsmittel
US4665181A (en) 1984-05-17 1987-05-12 Pennwalt Corporation Anti-inflammatory phthalazinones
CA1308516C (en) * 1987-07-06 1992-10-06 The Governors Of The University Of Alberta Oligopeptide anticancer and antiviral agents
IL90337A0 (en) 1988-05-24 1989-12-15 Pfizer Aromatic and heterocyclic carboxamide derivatives as antineoplastic agents
US4919199A (en) * 1989-01-13 1990-04-24 The Atlantic Group, Inc. Multiple locking stake for tube bundle
FR2656608B1 (fr) 1989-12-28 1992-04-24 Roussel Uclaf Nouvelles polyamines benzoylees, leur procede de preparation et leur application comme fongicides.
US5273991A (en) * 1992-07-29 1993-12-28 Research Corporation Technologies, Inc. Imidazole-containing compositions and methods of use thereof analogs of distamycin
IT1263089B (it) * 1993-04-26 1996-07-24 Menarini Farma Ind Composti pirrol-amidinici, processi di preparazione e composizioni farmaceutiche che li contengono.
US5698674A (en) * 1994-04-13 1997-12-16 The Regents Of The University Of California Triheterocyclic peptides capable of binding the minor and major grooves of DNA
GB9416005D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation
US5637621A (en) * 1994-11-14 1997-06-10 Nzym, Inc. Methods and compositions for treating Botrytis infections
US5801155A (en) * 1995-04-03 1998-09-01 Epoch Pharmaceuticals, Inc. Covalently linked oligonucleotide minor grove binder conjugates
US5767142A (en) * 1996-03-20 1998-06-16 Rutgers, The State University Of New Jersey Trisbenzimidazoles useful as topoisomerase I inhibitors
GB9516943D0 (en) * 1995-08-18 1995-10-18 Cancer Soc Auckland Div Nz Inc Novel cyclopropylindoles and their secoprecursors,and their use as prodrugs
JP2000503999A (ja) 1996-02-02 2000-04-04 フアルマシア・エ・アツプジヨン・エツセ・ピー・アー ジスタマイシン誘導体、その調製方法、および抗腫瘍および抗ウイルス剤としてのその使用
JP2001513759A (ja) * 1996-02-26 2001-09-04 カリフォルニア・インスティチュート・オブ・テクノロジー 二本鎖ｄｎａの副溝において結合する改良されたポリアミド
US6506906B1 (en) * 1996-02-26 2003-01-14 California Institute Of Technology Preparation and use of bifunctional molecules having DNA sequence binding specificity
US6143901A (en) 1996-07-31 2000-11-07 Genesoft, Inc. Complex formation between dsDNA and pyrrole imidazole polyamides
US6635417B1 (en) * 1996-07-31 2003-10-21 California Institute Of Technology Complex formation between DSDNA and oligomer of cyclic heterocycles
US6090947A (en) * 1996-02-26 2000-07-18 California Institute Of Technology Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
US5770617A (en) 1996-03-20 1998-06-23 Rutgers, The State University Of New Jersey Terbenzimidazoles useful as antifungal agents
CA2255703A1 (en) * 1996-05-31 1997-12-04 Dale L. Boger Analogs of cc-1065 and the duocarmycins
WO1998002441A2 (en) * 1996-07-12 1998-01-22 Ariad Pharmaceuticals, Inc. Non immunosuppressive antifungal rapalogs
JP2002515057A (ja) * 1996-08-01 2002-05-21 カリフォルニア・インスティチュート・オブ・テクノロジー ポリアミドｄｎａ結合リガンドによる遺伝子発現の阻害
GB9623522D0 (en) 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
US6251933B1 (en) * 1996-12-13 2001-06-26 The Cancer Research Campaign Technology Limited Seco precursors of cyclopropylindolines and their use as prodrugs
JP2001510057A (ja) * 1997-07-17 2001-07-31 ティーエム テクノロジーズ， インク． 核酸の融解温度を調節する方法及び組成
JPH11189594A (ja) 1997-12-25 1999-07-13 Mitsui Chem Inc アクリル酸誘導体を側鎖にもつピロリルベンズイミダゾール誘導体
US6008247A (en) * 1998-02-27 1999-12-28 The University Of North Carolina At Chapel Hill 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents
ES2198139T3 (es) * 1998-08-20 2004-01-16 The University Of North Carolina At Chapel Hill Compuestos de dibenzotiofeno y procedimientos de uso de los mismos.
GB9818730D0 (en) * 1998-08-27 1998-10-21 Univ Portsmouth Collections of compounds
ES2260570T3 (es) * 1998-08-27 2006-11-01 Spirogen Limited Pirrolobenziodiazepinas dimericas.
GB9818731D0 (en) * 1998-08-27 1998-10-21 Univ Portsmouth Compounds
JP2002524503A (ja) * 1998-09-17 2002-08-06 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル 二陽イオン分子の抗真菌活性
GB9908828D0 (en) * 1999-04-16 1999-06-16 Univ Reading The Compounds
CA2377902A1 (en) * 1999-07-08 2001-01-18 The University Of North Carolina At Chapel Hill Novel prodrugs for antimicrobial amidines
AU7381600A (en) 1999-09-17 2001-04-17 Genelabs Technologies, Inc. Covalently linked dimeric dna binding molecules
JP2003519623A (ja) * 1999-12-20 2003-06-24 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル Ｄｎａ小溝結合剤としてのジアミジン化合物
JP2001181279A (ja) 1999-12-28 2001-07-03 Mitsui Chemicals Inc ベンゾフラニルピロールカルボキシアミド誘導体
ATE362940T1 (de) * 2000-03-16 2007-06-15 Genesoft Inc Geladene verbindungen mit einer nukleinsäure- bindenden einheit sowie deren verwendungen
AU2001262974A1 (en) 2000-05-03 2001-11-12 The Scripps Research Institute Dna alkylating agent and activation thereof
WO2001096313A1 (en) 2000-06-14 2001-12-20 The Scripps Research Institute Distamycin a analogs
EP1294713A2 (en) 2000-06-27 2003-03-26 Genelabs Technologies, Inc. Compounds possessing antibacterial, antifungal or antitumor activity
GB0015904D0 (en) 2000-06-28 2000-08-23 Hoffmann La Roche Inhibitors of HPV E1 helicase enzyme
AU2001282070A1 (en) * 2000-07-11 2002-01-21 Universite De Geneve Linked, sequence-specific DNA-binding molecules
DE60115265T2 (de) * 2000-09-19 2006-08-10 Lee, Moses, Holland Zusammensetzungen und verfahren zur verwendung achiraler analoge von cc-1065 und den duocarmycinen
AU2002310764A1 (en) 2001-05-21 2002-12-03 Universite De Geneve Sequence-specific dna binding compounds and their use in targeting telomeres and other dna sequences
AU2002312370A1 (en) 2001-06-13 2002-12-23 Roland W. Burli Antipathogenic benzamide compounds
CA2450625A1 (en) 2001-06-13 2002-12-19 Genesoft Pharmaceuticals, Inc. Isoquinoline compounds having antiinfective activity
JP2003089652A (ja) 2001-09-20 2003-03-28 Meiji Seika Kaisha Ltd 抗口腔カンジダ症組成物
US20030187026A1 (en) * 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
GB0130868D0 (en) * 2001-12-24 2002-02-06 Univ Strathclyde New compounds
WO2003070450A1 (en) 2002-02-21 2003-08-28 Riken High-strength film of polyhydroxyalkanoic acid and process for producing the same
AU2003217782A1 (en) 2002-02-27 2003-09-09 The Government Of The United States Of America, Representated By The Secretary, Deparment Of Health Dna-binding polyamide drug conjugates
AU2003213836A1 (en) 2002-03-11 2003-09-29 Epoch Biosciences, Inc. Negatively charged minor groove binders
US7470717B2 (en) 2003-07-30 2008-12-30 Kyowa Hakko Kogyo Co., Ltd. Indazole derivatives

Also Published As

Publication number Publication date
US8012967B2 (en) 2011-09-06
EP2066627B1 (en) 2013-10-23
WO2008038018A1 (en) 2008-04-03
US20100016311A1 (en) 2010-01-21
DK2066627T3 (da) 2014-01-27
CN101589024B (zh) 2014-01-01
GB2455479C (en) 2012-05-16
GB0619325D0 (en) 2006-11-08
GB2455479B (en) 2009-10-28
EP2066627A1 (en) 2009-06-10
PL2066627T3 (pl) 2014-05-30
GB2455479A (en) 2009-06-17
HK1138281A1 (en) 2010-08-20
JP2010505757A (ja) 2010-02-25
CA2664847C (en) 2014-12-02
CA2664847A1 (en) 2008-04-03
CN101589024A (zh) 2009-11-25
GB0906908D0 (en) 2009-06-03
JP5564257B2 (ja) 2014-07-30

Similar Documents

Publication Publication Date Title
CA2664847C (en) Novel minor groove binders
JP4954983B2 (ja) Ｂｉｒドメイン結合化合物
CN108250159A (zh) 脲类化合物、其制备方法及其应用
Manfroni et al. Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase
WO2007131366A1 (en) Iap bir domain binding compounds
EA030941B1 (ru) Противовирусные соединения
WO2020142228A1 (en) Androgen receptor protein degraders
Al-Ansary et al. Molecular design and synthesis of HCV inhibitors based on thiazolone scaffold
JP2010174023A (ja) Ｄｎａ副溝結合化合物
Koval et al. DNA sequence-specific ligands. XVII. Synthesis, spectral properties, virological and biochemical studies of fluorescent dimeric bisbenzimidazoles DBA (n)
Babu et al. Synthesis, characterisation, anti-microbial activity and docking studies of novel Dispiro-Oxindolopyrrolidines
AU2020312791B2 (en) Fluorescent systems for biological imaging and uses thereof
JP2026032043A (ja) 化合物及びその使用
CN105658625A (zh) 作为细胞坏死阻碍剂的吲哚酰胺化合物
Champciaux et al. Synthesis and biological evaluation of 3, 4-dihydro-1H-[1, 4] oxazepino [6, 5, 4-hi] indol-1-ones and 4, 6-dihydrooxepino [5, 4, 3-cd] indol-1 (3H)-ones as Mycobacterium tuberculosis inhibitors
CN110028508B (zh) 一种抗肿瘤的重氮双环类细胞凋亡蛋白抑制剂
HK1138281B (en) Minor groove binders
CN102753166A (zh) 四肽类似物及其制备和应用
Romagnoli et al. α-Halogenoacrylic derivatives of antitumor agents
US20240287025A1 (en) Tetrahydroquinoline (thq) coumpounds
Bhalla et al. Synthesis of Diverse β-Lactams: Role of Appended Hetero Moiety on Its Activity
CN117337178A (zh) 化合物及其用途
Fagbure Small Molecule Inhibitors of the Endoplasmic Reticulum Associated Degradation Pathway